Shares Magazine
206.00p-8.00 (-3.74%)02 May 2025, 16:18
Jump to:
Maxcyte INC Fundamentals
| Company Name | Maxcyte INC | Last Updated | 2025-05-02 |
|---|---|---|---|
| Industry | Medical Devices | Sector | Healthcare |
| Shares in Issue | 106.028 m | Market Cap | £218.42 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -$0.39 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.0753 | Debt Equity Ratio | 0.0832 |
| Asset Equity Ratio | 1.1611 | Cash Equity Ratio | 0.7490 |
| Quick Ratio | 10.0896 | Current Ratio | 10.88 |
| Price To Book Value | 1.4656 | ROCE | 0 |
Maxcyte INC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Maxcyte INC Company Financials
| Assets | 2024 | 2023 | 2022 |
|---|---|---|---|
| Tangible Assets | $30.47 m | $34.75 m | $33.58 m |
| Intangible Assets | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Total Fixed Assets | $67.79 m | $78.08 m | $34.39 m |
| Stocks | $8.91 m | $12.23 m | $8.58 m |
| Debtors | 0 | 0 | 0 |
| Cash & Equivalents | $154.48 m | $168.29 m | $227.34 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | $239.47 m | $268.27 m | $286.65 m |
| Liabilities | 2024 | 2023 | 2022 |
|---|---|---|---|
| Creditors within 1 year | $15.78 m | $17.86 m | $15.43 m |
| Creditors after 1 year | $17.44 m | $18.25 m | $17.26 m |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | $33.22 m | $36.11 m | $32.69 m |
| Net assets | $206.25 m | $232.17 m | $253.97 m |
| Equity | 2024 | 2023 | 2022 |
|---|---|---|---|
| Called up share capital | $1.06 m | $1.04 m | $1.02 m |
| Share Premium | $422.05 m | $406.93 m | $390.82 m |
| Profit / Loss | -$41.05 m | -$37.92 m | -$23.57 m |
| Other Equity | $206.25 m | $232.17 m | $253.97 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | $206.25 m | $232.17 m | $253.97 m |
| Ratios | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt Ratio | $0.08 | $0.07 | $0.06 |
| Debt-to-Equity | $0.08 | $0.08 | $0.06 |
| Assets / Equity | 1.1611 | 1.1611 | 1.1611 |
| Cash / Equity | 0.7490 | 0.7490 | 0.7490 |
| EPS | -$0.39 | -$0.37 | -$0.23 |
| Cash Flow | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash from operating activities | -$27.61 m | -$21.69 m | -$14.78 m |
| Cashflow before financing | -$25.55 m | -$19.54 m | -$11.89 m |
| Increase in Cash | -$18.62 m | $35.44 m | -$36.72 m |
| Income | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | $38.63 m | $41.29 m | $44.26 m |
| Cost of sales | $7.10 m | $4.74 m | $5.10 m |
| Gross Profit | $31.53 m | $36.55 m | $39.16 m |
| Operating Profit | -$51.20 m | -$48.30 m | -$27.36 m |
| Pre-Tax profit | -$41.05 m | -$37.92 m | -$23.57 m |
Maxcyte INC Company Background
| Sector | Healthcare |
|---|---|
| Activities | MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies. |
| Latest Interim Date | 6 Aug 2024 |
| Latest Fiscal Year End Date | 11 Mar 2025 |
Maxcyte INC Directors
| Appointed | Name | Position |
|---|---|---|
| 2024-10-18 | Ms. Cynthia Lynne Collins | Director |
| 2025-03-20 | Mr. Douglas J Swirsky | CHIEF FINANCIAL OFFICER |
| 2024-11-06 | Mr. Stanley Charles Erck | Independent Director |
| 2024-06-14 | Mr. Patrick J Balthrop Sr | Independent Director |
| 2024-06-14 | Dr. Richard H. Douglas, PhD | Non-Executive Chairman of the Board |
| 2024-12-31 | Mr. Arthur Michael Mandell | Independent Director |
| 2025-01-31 | Mr. John Joseph Johnston | Independent Director |
| 2024-06-14 | Dr. Yasir B. Al-Wakeel, B.M. | Independent Director |
| 2023-12-28 | Mr. Douglas Arthur Doerfler | Executive Director,President and Chief Executive Officer |
| 2024-06-14 | Mr. William Wade Brooke | Independent Director |
| 2024-06-14 | Ms. Rekha Hemrajani, M.B.A. | Independent Director |
| 2022-03-29 | Ms. Amanda L. Murphy | Chief Financial Officer |
| 2024-08-05 | Mr. Thomas M. Ross | EVP, GLOBAL SALES |
| 2025-03-24 | Mr. Maher Masoud | Executive Director,President and Chief Executive Officer |
| 2023-03-21 | Mr. Cenk Sumen | Chief Scientific Officer |
| 2025-03-20 | Mr. David I. Sandoval | GENERAL COUNSEL |
| 2025-03-20 | Mr. Ali Soleymannezhad | Chief Commercial Officer |
Maxcyte INC Contact Details
| Company Name | MaxCyte Inc |
|---|---|
| Address | 22 Firstfield Road, Suite 110, Gaithersburg, 20878 |
| Telephone | +1 301 944-1700 |
| Website | https://www.maxcyte.com |
Maxcyte INC Advisors
| Registrar | Capita Asset Services |
|---|---|
| Phone | +44 1534847000 |
| Fax | +44 1534847001 |
| Auditor | Aronson LLC |
|---|---|
| Phone | +1 301 231-6200 |
| Fax | +1 301 231-7630 |
| Solicitor | Cooley LLP |
|---|---|
| Phone | +1 703 456-8000 |
| Financial PR Adviser | Consilium Strategic Communications |
|---|---|
| Phone | +44 2037095700 |
| Solicitor | Feldhaus Law Group, P.C. |
|---|
| Solicitor | Travers Smith LLP |
|---|---|
| Phone | +44 2072953000 |
| Fax | +44 2072953500 |
| Solicitor | Norton Rose Fulbright US LLP |
|---|
| Nominated Adviser | Panmure Gordon (UK) Ltd |
|---|---|
| Phone | +44 2078862500 |
| Stockbroker | Panmure Gordon (UK) Ltd |
|---|---|
| Phone | +44 2078862500 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Ferrexpo PLC | 77.70 | 7.92 |
| Clarkson PLC | 3,190.00 | 6.51 |
| Senior PLC | 146.20 | 6.25 |
| Alfa Financial Software Holdings PLC | 232.00 | 5.45 |
| Harbour Energy PLC | 160.90 | 5.23 |
| International Consolidated Airlines Group S.A. | 279.00 | 5.01 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Mobico Group PLC | 30.56 | -3.78 |
| Just Group PLC | 138.00 | -2.95 |
| Tbc Bank Group PLC | 4,700.00 | -2.89 |
| Sirius Real Estate LD | 93.10 | -2.82 |
| Ocado Group PLC | 274.20 | -2.80 |
| Watches Of Switzerland Group PLC | 349.40 | -2.62 |